Middle-East And Africa In-vitro Fertilization Market Overview
In-vitro fertilization (IVF) involves the fertilization of ovum using laboratory settings followed by implantation into uterus. In-vitro fertilization is also known as assisted reproductive technology. The process involves the collection of matured healthy eggs and sperms from the partners, or known or anonymous donors. These eggs get fertilized using laboratory reagents & media and instruments. Fertilized eggs (embryos) are implanted into uterus for the continuation of development of embryo to child. One cycle of in-vitro fertilization takes around 10-15 days. IVF is most widely accepted method for the fertility treatments in clinical industry and helpful for the couples with infertility problems, single mothers, as well as LGBT communities. The major product categories that assist in-vitro fertilization method include reagents & media (such as embryo culture media, sperm processing media) and instruments (sperm separation system, cryosystems).
Increasing government initiatives for the development of healthcare infrastructure, growing lifestyle & gynecological disorders in certain countries of Middle East & Africa, decreasing rates of pregnancies among women, and rising number of the population are driving the growth of in-vitro fertilization market in the Middle East & Africa. However, unawareness of advanced fertilization technologies, the requirement of high cost for the running of in-vitro fertilization procedures, lack of technical experts, and scarcity of advanced in-vitro fertilization methods are expected to restrain the growth of in-vitro fertilization market in the Middle East & Africa.
Middle-East And Africa In-vitro Fertilization Market Forecast Report (2018-2023)
Middle East and Africa in-vitro fertilization (IVF) market are expected to reach USD 0.46 billion by 2023 from USD 0.22 billion in 2018, growing at a CAGR of 16.64% during the forecast period 2018-2023.
Middle-East And AfricaIn-vitro Fertilization Market Segmentation
Middle East and Africa in-vitro fertilization market are segmented based on reagents & media, instruments, technology, and end users. Based on reagents & media, the market is further sub-segmented as embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Of these, cryopreservation media accounted for the largest share of the Middle East and Africa in-vitro fertilization market by reagents & media in 2018. Based on instruments, the market is segmented as imaging systems, sperm separation systems, ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, and other instruments (gas analyzers, laser systems, accessories). Of these, imaging systems commanded the largest share of the Middle East and Africa in-vitro fertilization market by instruments in 2018, whereas, sperm separation systems segment is expected to grow at the highest CAGR during the forecast period 2018-2020.
Based on technology, the market is segmented as intra-cytoplasmic sperm injection, pre-implantation genetic diagnosis, frozen embryo transfer/replacement, and other technologies. Among these, intra-cytoplasmic sperm injection segment accounted for the largest share of the Middle East and Africa in-vitro fertilization market by technology in 2018. Based on end users, the market is segmented as fertility & surgical centers, hospitals & research laboratories, and cryobanks. Of these, fertility & surgical centers segment commanded the largest share of the Middle East and Africa in-vitro fertilization market by end users in 2018.
On the basis of geographical areas, the Middle East and Africa in-vitro fertilization market are segmented as the Middle East and South Africa.
Major Players:
The key players in the Middle-East And Africa in-vitro fertilization market such as,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Introduction
5.2 Reagents and Media
5.2.1 Introduction
5.2.2 Embryo Culture Media
5.2.3 Cryopreservation Media 5.2.2.1 Autologous Cell-Based Products
5.2.4 Sperm Processing Media 5.2.2.2 Allogeneic Cell-Based Products
5.2.5 Ovum Processing Media
5.3 Instruments
5.3.1 Introduction
5.3.2 Imaging Systems
5.3.3 Sperm Separation Systems
5.3.4 Ovum Aspiration Pumps
5.3.5 Incubators
5.3.6 Micromanipulator Systems
5.3.7 Cryosystems
5.3.8 Other Instruments (Gas Analyzers, Laser Systems, Accessories)
5.4 Technology
5.3.1 Introduction
5.3.2 Intra-Cytoplasmic Sperm Injection (ICSI)
5.3.3 Pre-Implantation Genetic Diagnosis (PGD)
5.3.4 Frozen Embryo Transfer/Replacement (FET/FER)
5.3.5 Other Technologies
5.5 End Users
5.4.1 Introduction
5.4.2 Fertility and Surgical Centers
5.4.3 Hospitals and Research Laboratories
5.4.4 Cryobanks
6.5.1 Introduction
6.5.2 Middle East
6.5.2 South Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 CooperSurgical, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Cook Medical, Inc. (U.S.)
8.3 Irvine Scientific (U.S.)
8.4 Vitrolife AB (Sweden)
8.5 Thermo Fisher Scientific, Inc. (U.S.)
8.6 EMD Serono, Inc. (U.S.)
8.7 Genea Limited (Australia)
8.8 ESCO Micro Pte. Limited (Singapore)
8.9 IVFtech ApS (Denmark)
8.10 The Baker Company, Inc. (U.S.)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
